418
Views
13
CrossRef citations to date
0
Altmetric
Research Papers

A careful biomedicine? Generalization and abstraction in RCTs

ORCID Icon & ORCID Icon
Pages 181-191 | Received 03 Jul 2017, Accepted 07 Jan 2018, Published online: 29 Jan 2018

References

  • Beeching, N. J., Fenech, M., & Houlihan, C. F. (2014). Ebola virus disease. BMJ, 349, g7348.10.1136/bmj.g7348
  • Puig de la Bellacasa, M. (2011). Matters of care in technoscience: Assembling neglected things. Social Studies of Science, 41(1), 85–106.10.1177/0306312710380301
  • Bonell, C. (2002). The utility of randomized controlled trials of social interventions: An examination of two trials of HIV prevention. Critical Public Health, 12(4), 321–334.10.1080/0958159021000029504a
  • Brown, C. H., Ten Have, T. R., Jo, B., Dagne, G., Wyman, P. A., Muthén, B., & Gibbons, R. D. (2009). Adaptive designs for randomized trials in public health. Annu Rev Public Health, 29(30), 1–25.
  • Cambrosio, A., Keating, P., Schlich, T., & Weisz, G. (2009). Biomedical conventions and regulatory objectivity: A few introductory remarks. Social Studies of Science, 39(5), 651–664.10.1177/0306312709334640
  • Chow, S., & Chang, M. (2008). Adaptive design methods in clinical trials–a review. Orphanet Journal of Rare Diseases, 3, 11.10.1186/1750-1172-3-11
  • Dunning, J., Sahr, F., Rojek, A., Gannon, F., Carson, G., Idriss, B. … Brooks, T. J. (2016). Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial. PLOS Medicine, 13(4), e1001997. doi:10.1371/journal.pmed.1001997
  • Freedman, B. (1987). Equipoise and the ethics of clinical research. New England Journal of Medicine, 317, 141–145.10.1056/NEJM198707163170304
  • Greenhalgh, T., Howick, J., & Maskrey, N. (2014). Evidence based medicine: A movement in crisis? BMJ, 348(jun13), g3725–g3725. doi:10.1136/bmj.g3725
  • Halewood, M. (2011). A.N. Whitehead and social theory: Tracing a culture of thought. London: Anthem Press.
  • Howick, J. (2011). The philosophy of evidence-based medicine. Oxford: Wiley-Blackwell.10.1002/9781444342673
  • Kanters, S. (2014). Evaluating Ebola interventions: Adaptive designs should be commonplace. The Lancet Global Health Blog. 10 October. Retrieved November 2014, from http://globalhealth.thelancet.com/2014/10/10/evaluating-ebola-interventions-adaptive-designs-should-be-commonplace
  • Kippax, S., & Van den Ven, P. (1998). An epidemic of orthodoxy? Design and methodology in the evaluation of the effectiveness of HIV health promotion. Critical Public Health, 8(4), 371–386.10.1080/09581599808402921
  • Kirchoff, M. C., & Pierson, J.F. (2017). Considerations for use of investigational drugs in public health emergencies. Therapeutic Innovation & Regulatory Science, 51(2), 146–152.
  • Krause, P. R. (2015). Interim results from a phase 3 Ebola vaccine study in Guinea. The Lancet, 386(9996), 831–833.10.1016/S0140-6736(15)00002-1
  • Latour, B. (1988). Science in action: How to follow scientists and engineers through society. Cambridge, MA: Harvard University Press.
  • Michael, M., & Rosengarten, M. (2013). Innovation and biomedicine: Ethics, evidence and expectation in HIV. London: Palgrave MacMillan.10.1057/9781137316677
  • Montgomery, C. (2017). From standardization to adaptation: Clinical trials and the moral economy of anticipation. Science as Culture, 26(2), 232–254.10.1080/09505431.2016.1255721
  • Puig de la Bellacasa, M. (2017). Matters of care. Minneapolis, MN: University of Minnesota Press.
  • Pulliam, J. R. C., Bellan, S. E., Gambhir, M., Meyers, L. A., & Dushoff, J. (2015). Evaluating Ebola vaccine trials: Insights from simulation. The Lancet Infectious Diseases, 15(10), 1134.10.1016/S1473-3099(15)00303-5
  • Robinson, J. E., & Norris, N.F.J. (2001). Generalisation: The linchpin of evidence-based practice? Educational Action Research, 9(2), 303–310.10.1080/09650790100200155
  • Rod, M. H., Ingholt, L., Sørensen, B. B., & Tjørnhøj-Thomsen, T. (2014). The spirit of the intervention: Reflections on social effectiveness in public health intervention research. Critical Public Health, 24(3), 296–307.10.1080/09581596.2013.841313
  • Rothwell, P. M. (2005). External validity of randomised controlled trials: ‘To whom do the results of this trial apply?’. The Lancet, 365(9453), 82–93.10.1016/S0140-6736(04)17670-8
  • Savransky, M. (2016). The adventure of relevance: An ethics of social inquiry. Basingstoke: Palgrave Macmillan.10.1057/978-1-137-57146-5
  • Singal, A. M., Higgins, P. D. R., & Waljee, A. K. (2014). A primer on effectiveness and efficacy trials clinical/narrative review. Clinical and Translational Gastroenterology, 5(1), e45.10.1038/ctg.2013.13
  • Stengers, I. (2008). A constructivist reading of process and reality. Theory, Culture and Society, 25(4), 91–110.10.1177/0263276408091985
  • The Prevail Writing Group (2016). A randomized, controlled trial of ZMapp for Ebola virus infection. New England Journal of Medicine, 375, 1448–1456.
  • Thorpe, K. E., Zwarenstein, M., Oxman, A. D., Treweek, S., Furberg, C. D., Altman, D. G., … Chalkidou, K. (2009). A pragmatic-explanatory continuum indicator summary (PRECIS): A tool to help trial designers. Journal of Clinical Epidemiology, 62(5), 464–475.10.1016/j.jclinepi.2008.12.011
  • Timmermans, S., & Berg, M. (2003). The gold standard: The challenge of evidence-based medicine and standardization in health care. Philadelphia, PA: Temple University Press.
  • Treweek, S., & Zwarenstein, M. (2009). Making trials matter: Pragmatic and explanatory trials and the problem of applicability. Trials 10:37 Retrieved October 14, 2014, from http://www.trialsjournal.com/content/10/1/37
  • Valters, C., Cummings, C., & Nixon, H. (2016). Putting learning at the centre adaptive development programming in practice. London: Report by Overseas Development Institute.
  • Victora, C. G., Habicht, J., & Bryce, J. (2004). Evidence-based public health: Moving beyond randomized trials. American Journal of Public Health, 94(3), 400–405.10.2105/AJPH.94.3.400
  • Walker, C., & Jacobs, S. (2002). Social structures of science and approaches to outcomes-based medical research. Critical Public Health, 12(4), 309–320.10.1080/0958159021000029522
  • White, D. G. (2001). Evaluating evidence and making judgements of study quality: Loss of evidence and risks to policy and practice decisions. Critical Public Health, 11(1), 3–17.10.1080/09581590010028228
  • Whitehead, A. N. (1927). Symbolism: Its meaning and effect. New York, NY: Fordham University Press.
  • Whitehead, A. N. (1967). Science and the modern world. New York, NY: Free Press.
  • Whitehead, J., Olliaro, P., Lang, T., & Horby, P. (2016). Trial design for evaluating novel treatments during an outbreak of an infectious disease. Clinical Trials: Journal of the Society for Clinical Trials, 13(1), 31–38.10.1177/1740774515617740
  • Will, C. M., & Moreira, T. (2010). Medical proofs, social experiments: Clinical trials in shifting contexts. Farnham: Ashgate.
  • Yin, G., Lam, C. K., & Shi, H. (2017). Bayesian randomized clinical trials: From fixed to adaptive design. Contemporary Clinical Trials, 59, 77–86.10.1016/j.cct.2017.04.010
  • Zwarenstein, M., & Treweek, S. (2009). What kind of randomised trials do patients and clinicians need? Annuals of Internal Medicine, 150(10), 5–3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.